Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
NTRA - Natera, Inc.
Market Cap 4.56B P/E - EPS this Y -8.10% Ern Qtrly Grth -
Income -545.79M Forward P/E -9.06 EPS next Y 17.40% 50D Avg Chg 6.00%
Sales 776M PEG - EPS past 5Y - 200D Avg Chg -
Dividend N/A Price/Book 11.26 EPS next 5Y - 52W High Chg -44.00%
Recommedations 1.90 Quick Ratio 2.83 Shares Outstanding 97.60M 52W Low Chg 60.00%
Insider Own 3.38% ROA -29.03% Shares Float 93.90M Beta 1.29
Inst Own 87.03% ROE -97.41% Shares Shorted/Prior 5.39M/5.01M Price 41.84
Gross Margin 45.48% Profit Margin -70.33% Avg. Volume 1,676,657 Target Price 74.31
Oper. Margin -69.45% Earnings Date Feb 22 Volume 424,791 Change -4.34%
Healthcare | Diagnostics & Research | United States
About Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.

Natera, Inc. News
01/24/23 Raymond James Sees ‘Multiple Expansion’ to Drive Stock Market Returns — Here Are 2 Stocks to Play That Bullish Sentiment
01/19/23 New Signatera™ MRD Data in Gastrointestinal Cancers to be Presented at the ASCO GI Symposium 2023
01/18/23 Raymond James Upgrades Natera & Myriad Genetics, While Downgrading This Stock
01/17/23 Natera Announces Publication of Prospective, Multi-Site CIRCULATE Study in Nature Medicine Demonstrating Signatera’s Ability to Predict Chemotherapy Benefit in Colorectal Cancer
01/12/23 Wall Street Analysts Think Natera (NTRA) Could Surge 82.88%: Read This Before Placing a Bet
01/03/23 Natera to Webcast Live Presentation at the 41st Annual J.P. Morgan Healthcare Conference
01/03/23 A Natera, Inc. (NASDAQ:NTRA) insider increased their holdings by 13% last year
12/21/22 Natera Supports Updated ISHLT Guidelines for the Care of Heart Transplant Patients
12/09/22 Natera Announces Publication of Multi-Center Study Validating Signatera's Ability to Predict Recurrence in Esophageal and Gastric Cancers
12/07/22 After losing 58% in the past year, Natera, Inc. (NASDAQ:NTRA) institutional owners must be relieved by the recent gain
12/07/22 Natera to Present New Signatera™ and Empower™ Data at the 2022 Annual San Antonio Breast Cancer Symposium
12/06/22 Natera Announces Publication of Clinical Experience Study with 18,984 Twin Pregnancies Supporting Excellent Performance of Panorama™ NIPT
12/05/22 13 Best Genomics Stocks To Buy Now
11/23/22 Natera to Participate in the Piper Sandler 34th Annual Healthcare Conference
11/22/22 Biotech companies Natera and Synthego are laying off a total of 163 employees
11/21/22 New Published Study Further Demonstrates the Ability of Natera's mPCR Technology to Monitor Immunotherapy Response in Metastatic Uveal Melanoma Patients
11/15/22 Natera Announces Pricing of Follow-On Offering
11/15/22 Natera Launches Proposed Follow-On Offering
11/10/22 Natera Third Quarter 2022 Earnings: Beats Expectations
11/08/22 Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
NTRA Chatroom

User Image acceleration5000 Posted - 2 days ago

$NTRA Broke downtrend from August. Moving averages flattening out. MACD recently crossed and positive.

User Image tickeron Posted - 4 days ago

How to make the right investment? Compare $NTRA vs. $SEEL. #Natera https://srnk.us/go/4347923

User Image commoncentsinvestor Posted - 5 days ago

$NTRA Anyone with dry powder should take a look at this rising star. 2022 was brutal to stocks in the small cap category. But one little known company has been a great investment. It is CVRX and to show how little known it is, it has only 390 followers on stock twits. Six months ago it was $5 per share. Today it is over $14. Last year it received FDA approval for its Barostim treatment for heart failure victims. It is a game changer for heart patients and is being rapidly adopted by hospitals and doctors. It also has over $5 per share in CASH and was named #2 in the Top Ten heart disease startups: medicalstartups.org/top/heart/ With a current Market Cap of only $300M, once the Market discovers this little gem it could easily become a 5 to 10 bagger. A real shining star in a sky full of dark clouds.

User Image Monkey_Banana_Genius Posted - 5 days ago

$ntra added 39.90s

User Image SweepCast Posted - 5 days ago

SweepCast ⚡ Unusual Options Detected: $NTRA with Unusual Options Activity Alerted on $45 CALL Expiring: 02-17-2023 worth 26K🐂 |🥇 Start Using SweepCast! @SweepCast 🥇 |

User Image MarketBeatInsiderTrades Posted - 5 days ago

Natera CFO Michael Burkes Brophy Sells $94,465.88 in $NTRA www.marketbeat.com/stocks/NASDAQ/NTRA/insider-trades/

User Image MarketBeatInsiderTrades Posted - 5 days ago

Natera COO Robert Alan Schueren Sells $176,879.36 in $NTRA www.marketbeat.com/stocks/NASDAQ/NTRA/insider-trades/

User Image MarketBeatInsiderTrades Posted - 5 days ago

Natera Insider Daniel Rabinowitz Sells $99,203.72 in $NTRA www.marketbeat.com/stocks/NASDAQ/NTRA/insider-trades/

User Image MarketBeatInsiderTrades Posted - 5 days ago

Natera CEO Steven Leonard Chapman Sells $223,177.20 in $NTRA www.marketbeat.com/stocks/NASDAQ/NTRA/insider-trades/

User Image insiderbuyingselling Posted - 5 days ago

$NTRA new insider selling: 5370 shares. http://insiderbuyingselling.com/?t=NTRA

User Image Newsfilter Posted - 5 days ago

$NTRA reported 4 new insider trades to the SEC in the last 2 minutes. $99,203.72 of shares sold by Rabinowitz Daniel (SEC. AND CHIEF LEGAL OFFICER) https://newsfilter.io/articles/4-form-c7a9ff0c0e1a5dfac30f39a193487f05 $223,177.20 of shares sold by Chapman Steven Leonard (CEO AND PRESIDENT) https://newsfilter.io/articles/4-form-e948941198b34380c18c314304427106 $94,465.88 of shares sold by Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) https://newsfilter.io/articles/4-form-344de1166c087ae029238a7ccf32a17d $176,879.36 of shares sold by Schueren Robert Alan (CHIEF OPERATING OFFICER) https://newsfilter.io/articles/4-form-b6bf92745f373a0acc4776b9e3d722ab

User Image risenhoover Posted - 5 days ago

Insider Daniel Rabinowitz reports selling 2,387 shares of $NTRA for a total cost of $99,203.00 https://fintel.io/n/us/ntra/rabinowitz-daniel?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=insider

User Image Quantisnow Posted - 5 days ago

$NTRA 📜 SEC Form 4: Schueren Robert Alan converted options into 8,482 shares, sold $176,878 worth of shares (4,256 units at $41.56) as part of a pre-agreed trading plan and gifted 1,100 shares to satisfy tax liability https://quantisnow.com/i/3949411?utm_source=stocktwits 45 seconds delayed.

User Image stockilluminati Posted - 5 days ago

$NTRA https://www.stockilluminati.com/ntra/filings.php - Natera, Inc. - Common Stock files form 4 today, check out the details.

User Image risenhoover Posted - 5 days ago

Insider Robert Alan Schueren reports selling 4,256 shares of $NTRA for a total cost of $176,878.08 https://fintel.io/n/us/ntra/schueren-robert-alan?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=insider

User Image risenhoover Posted - 5 days ago

Insider Steven Leonard Chapman reports selling 5,370 shares of $NTRA for a total cost of $223,175.59 https://fintel.io/n/us/ntra/chapman-steven-leonard?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=insider

User Image risenhoover Posted - 5 days ago

Insider Michael Burkes Brophy reports selling 2,273 shares of $NTRA for a total cost of $94,465.20 https://fintel.io/n/us/ntra/brophy-michael-burkes?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=insider

User Image Newsfilter Posted - 5 days ago

$NTRA Form 4 (statement of changes in beneficial ownership of securities) filed with the SEC https://newsfilter.io/a/f5e34428d9a1ee25751837f6a57f83fc

User Image SweepCast Posted - 6 days ago

SweepCast ⚡ Unusual Options Detected: $NTRA with Unusual Options Activity Alerted on $45 CALL Expiring: 02-17-2023 worth 26K🐂 |🥇 Start Using SweepCast! @SweepCast 🥇 |

User Image Monkey_Banana_Genius Posted - 6 days ago

$NTRA this and exas are the 2 leaders and molecular diagnostics

User Image stockilluminati Posted - 6 days ago

$NTRA https://www.stockilluminati.com/ntra/filings.php - Natera, Inc. - Common Stock files form SC 13G/A today, check out the details.

User Image cctranscripts Posted - 6 days ago

JPMORGAN CHASE & CO. just provided an update on share ownership of Natera, Inc. https://www.conferencecalltranscripts.org/summary/?id=11717321 $NTRA

User Image fla Posted - 6 days ago

$NTRA [15s. delayed] filed form SC 13G/A on January 23, 12:34:33 https://s.flashalert.me/q0Owvy

User Image Quantisnow Posted - 6 days ago

$NTRA 📜 SEC Form SC 13G/A filed by Natera Inc. (Amendment) https://quantisnow.com/i/3940132?utm_source=stocktwits 45 seconds delayed.

User Image Newsfilter Posted - 6 days ago

$NTRA Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC https://newsfilter.io/a/7630d22ec6c9945499588e53efe13eac

User Image Monkey_Banana_Genius Posted - 1 week ago

$NTRA such an under the radar play

User Image BidaskBot Posted - 1 week ago

Natera $NTRA BidaskScore is #Reiterated to Sold https://bidaskclub.com/news/company/2023-01-19/NTRA

User Image ChartMill Posted - 1 week ago

$NTRA shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.38%. https://www.chartmill.com/stock/quote/NTRA/fundamental-analysis?key=efa5b41f-3073-4f75-b7ff-4e83c1380bc0&utm_source=stocktwits&utm_medium=FA&utm_content=NTRA&utm_campaign=social_tracking

User Image healthcareguru Posted - 1 week ago

$NTRA $GH both of these are two of the best growth assets in the entirety of the Diagnostics space and are now trading at all time low valuations…I’d be buying the hell out of these in my “forever” portfolio. Also like $VCYT …can short $NVTA $EXAS (exas is tactical) on other side. 👍

User Image Monkey_Banana_Genius Posted - 1 week ago

$ntra new long 38.60s

Analyst Ratings
Credit Suisse Outperform Nov 14, 22
Credit Suisse Outperform Aug 25, 22
Piper Sandler Overweight Aug 18, 22
JP Morgan Overweight Aug 5, 22
Piper Sandler Overweight May 16, 22
Morgan Stanley Overweight May 9, 22
Stephens & Co. Overweight Aug 31, 22
Goldman Sachs Buy Apr 19, 22
Piper Sandler Overweight Mar 21, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL.. SEC. AND CHIEF LEGAL OFFICER Jan 20 Sell 41.56 2,387 99,204 148,853 01/24/23
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Jan 20 Sell 41.56 5,370 223,177 103,779 01/24/23
Brophy Michael Burkes CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jan 20 Sell 41.56 2,273 94,466 103,023 01/24/23
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Jan 20 Sell 41.56 4,256 176,879 4,226 01/24/23
Sheena Jonathan - - Jan 20 Sell 41.56 51 2,120 520,616 01/24/23
HEALY JAMES Director Director Nov 16 Sell 37.7075 2,400 90,498 01/18/23
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Jan 07 Sell 37.62 2,244 84,419 7,886 01/10/23
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Jan 07 Option 13.01 3,938 51,233 11,824 01/10/23
Sheena Jonathan - - Dec 31 Sell 39.55 1,236 48,884 570,074 01/04/23
Rabinowitz Matthew EXECUTIVE CHAIRMAN EXECUTIVE CHAIRMAN Dec 31 Sell 39.55 2,706 107,022 639,803 01/04/23
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Dec 31 Sell 39.55 4,856 192,055 6,145 01/04/23
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Dec 31 Sell 39.55 8,212 324,785 93,831 01/04/23
Brophy Michael Burkes CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Dec 31 Sell 39.55 3,644 144,120 96,814 01/04/23
Sheena Jonathan - - Dec 27 Sell 39.84 134 5,339 567,169 12/29/22
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Dec 27 Sell 40.11 7,279 291,961 103,417 12/29/22
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL.. SEC. AND CHIEF LEGAL OFFICER Dec 27 Sell 39.84 728 29,004 147,172 12/29/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Dec 27 Sell 39.84 2,605 103,783 85,210 12/29/22
Brophy Michael Burkes CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Dec 27 Sell 39.84 915 36,454 91,350 12/29/22
Brophy Michael Burkes CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Dec 22 Sell 42.3 429 18,147 89,974 12/27/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Dec 22 Sell 42.3 1,660 70,218 82,632 12/27/22
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL.. SEC. AND CHIEF LEGAL OFFICER Dec 22 Sell 42.3 476 20,135 146,537 12/27/22
Sheena Jonathan - - Dec 22 Sell 42.3 136 5,753 566,856 12/27/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Dec 07 Option 11.15 10,304 114,890 83,630 12/09/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Dec 07 Sell 38.31 2,645 101,330 80,985 12/09/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Dec 07 Sell 38.31 2,645 101,330 80,985 12/09/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Dec 07 Option 11.15 10,304 114,890 83,630 12/09/22
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Oct 21 Sell 42.41 3,135 132,955 4,932 10/25/22
Sheena Jonathan - - Oct 21 Sell 42.41 44 1,866 566,537 10/25/22
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL.. SEC. AND CHIEF LEGAL OFFICER Oct 21 Sell 42.41 350 14,843 146,121 10/25/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Oct 21 Sell 42.41 905 38,381 73,326 10/25/22
Brophy Michael Burkes CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Oct 21 Sell 42.41 2,488 105,516 89,326 10/25/22
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Oct 18 Option 13.01 1,922 25,005 1,922 10/19/22
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Oct 07 Sell 42.12 2,008 84,577 3,915 10/11/22
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Sep 27 Sell 44.04 1,382 60,863 1,939 09/29/22
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL.. SEC. AND CHIEF LEGAL OFFICER Sep 27 Sell 44.04 729 32,105 145,827 09/29/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Sep 27 Sell 44.04 2,606 114,768 70,891 09/29/22
Brophy Michael Burkes CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Sep 27 Sell 44.04 915 40,297 85,669 09/29/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Sep 22 Sell 45.3 1,674 75,832 68,313 09/26/22
Brophy Michael Burkes CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Sep 22 Sell 45.3 433 19,615 84,292 09/26/22
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL.. SEC. AND CHIEF LEGAL OFFICER Sep 22 Sell 45.3 481 21,789 145,192 09/26/22
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Jul 21 Sell 46.26 572 26,461 572 07/25/22
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL.. SEC. AND CHIEF LEGAL OFFICER Jul 21 Sell 46.26 342 15,821 144,780 07/25/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Jul 21 Sell 46.26 886 40,986 69,805 07/25/22
Brophy Michael Burkes CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jul 21 Sell 46.26 454 21,002 83,648 07/25/22
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Jul 20 Option 13.01 1,281 16,666 4,607 07/22/22
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Jul 07 Sell 39.51 2,019 79,771 3,326 07/11/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Jul 02 Sell 36.93 1,550 57,242 68,916 07/06/22
Schueren Robert Alan CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER Jun 27 Sell 39.02 1,390 54,238 1,360 06/29/22
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL.. SEC. AND CHIEF LEGAL OFFICER Jun 27 Sell 39.02 689 26,885 144,478 06/29/22
Chapman Steven Leonard CEO AND PRESIDENT CEO AND PRESIDENT Jun 27 Sell 39.01 2,619 102,167 67,341 06/29/22